{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:32:41Z","timestamp":1649133161744},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/europace\/euz045","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T12:10:46Z","timestamp":1551096646000},"page":"999-1000","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of mortality and heart transplantation in patients with Chagas\u2019 cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators: commentary"],"prefix":"10.1093","volume":"21","author":[{"given":"Martino","family":"Martinelli Filho","sequence":"first","affiliation":[{"name":"Heart Institute (InCor) - Pacameker Clinic - University of S\u00e3o Paulo Medical School, Av. Eneas de Carvalho Aguiar, S\u00e3o Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"2019071004560835100_euz045-B1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas disease in Europe: a review for the internist in the globalized world","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2019071004560835100_euz045-B2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas' heart disease","volume":"355","author":"Rassi","year":"2006","journal-title":"N Engl J Med"},{"key":"2019071004560835100_euz045-B3","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"key":"2019071004560835100_euz045-B4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1540-8167.2003.02278.x","article-title":"Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol","volume":"14","author":"Leite","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2019071004560835100_euz045-B5","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.jacc.2018.08.2195","article-title":"Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy","volume":"72","author":"Senra","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2019071004560835100_euz045-B6","first-page":"1070","article-title":"Predictors of mortality and heart transplantation in patients with Chagas\u2019 cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators","volume-title":"Europace","author":"Gali","year":"2019"},{"key":"2019071004560835100_euz045-B7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2012.05.040","article-title":"Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas\u2019 heart disease","volume":"110","author":"Martinelli","year":"2012","journal-title":"Am J Cardiol"},{"key":"2019071004560835100_euz045-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eut422","article-title":"Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone","volume":"16","author":"Gali","year":"2014","journal-title":"Europace"},{"key":"2019071004560835100_euz045-B9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2018.05.091","article-title":"Implantable cardioverter-defibrillator in Chagas heart disease: a systematic review and meta-analysis of observational studies","volume":"267","author":"Carmo","year":"2018","journal-title":"Int J Cardiol"},{"key":"2019071004560835100_euz045-B10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ahj.2013.08.027","article-title":"CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial","volume":"166","author":"Martinelli","year":"2013","journal-title":"Am Heart J"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/21\/7\/999\/28918092\/euz045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T08:58:26Z","timestamp":1562749106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/21\/7\/999\/5418564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euz045","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,21]]}}}